PL3325081T3 - Sposoby dostarczania limfatycznego środków czynnych - Google Patents

Sposoby dostarczania limfatycznego środków czynnych

Info

Publication number
PL3325081T3
PL3325081T3 PL16831144T PL16831144T PL3325081T3 PL 3325081 T3 PL3325081 T3 PL 3325081T3 PL 16831144 T PL16831144 T PL 16831144T PL 16831144 T PL16831144 T PL 16831144T PL 3325081 T3 PL3325081 T3 PL 3325081T3
Authority
PL
Poland
Prior art keywords
methods
active agents
lymphatic delivery
lymphatic
delivery
Prior art date
Application number
PL16831144T
Other languages
English (en)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics, Inc. filed Critical Sorrento Therapeutics, Inc.
Publication of PL3325081T3 publication Critical patent/PL3325081T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Cosmetics (AREA)
PL16831144T 2015-07-24 2016-07-22 Sposoby dostarczania limfatycznego środków czynnych PL3325081T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562196558P 2015-07-24 2015-07-24
US201562196568P 2015-07-24 2015-07-24
PCT/US2016/043656 WO2017019535A2 (en) 2015-07-24 2016-07-22 Methods for lymphatic delivery of active agents
EP16831144.7A EP3325081B1 (en) 2015-07-24 2016-07-22 Methods for lymphatic delivery of active agents

Publications (1)

Publication Number Publication Date
PL3325081T3 true PL3325081T3 (pl) 2021-12-20

Family

ID=57885089

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831144T PL3325081T3 (pl) 2015-07-24 2016-07-22 Sposoby dostarczania limfatycznego środków czynnych

Country Status (15)

Country Link
US (3) US10737082B2 (pl)
EP (2) EP3922238A1 (pl)
JP (3) JP6929829B2 (pl)
KR (1) KR20180035210A (pl)
CN (1) CN107949418B (pl)
AU (3) AU2016297832B2 (pl)
BR (1) BR112018001435A2 (pl)
CA (1) CA2991459A1 (pl)
DK (1) DK3325081T3 (pl)
ES (1) ES2893673T3 (pl)
HU (1) HUE056424T2 (pl)
MX (2) MX2018000126A (pl)
PL (1) PL3325081T3 (pl)
RU (1) RU2719946C2 (pl)
WO (1) WO2017019535A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
US20200206352A1 (en) * 2017-08-31 2020-07-02 Tohoku University Optimal osmotic range for a drug-containing solution suitable for lymphatic delivery
WO2021113585A1 (en) 2019-12-05 2021-06-10 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device
JP7509402B2 (ja) * 2020-02-26 2024-07-02 国立大学法人 和歌山大学 解析装置、センシングシステム、解析装置の動作方法、及び、コンピュータプログラム
CN117813128A (zh) 2021-01-22 2024-04-02 索伦托药业有限公司 用于微升级淋巴递送冠状病毒疫苗的装置
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2022261262A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
CN113368385A (zh) * 2021-06-21 2021-09-10 温州医科大学慈溪生物医药研究院 利用淋巴通路递送生物大分子药物入脑的输送系统
US20250120905A1 (en) 2021-08-18 2025-04-17 Vivasor, Inc Therapeutic agents targeting the lymphatic system
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
NZ516582A (en) * 2000-06-01 2004-08-27 Watson Pharmaceuticals Inc Transdermal delivery of lasofoxifene
WO2003022330A2 (en) * 2001-09-12 2003-03-20 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
AU2004206853A1 (en) * 2003-01-16 2004-08-05 Becton, Dickinson And Company Intradermal cellular delivery using narrow gauge micro-cannula
JP2007500251A (ja) * 2003-06-13 2007-01-11 ベクトン・ディキンソン・アンド・カンパニー 生物学的に活性な作用物質の改良型皮内送達
US20050180952A1 (en) 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
WO2007019678A1 (en) 2005-08-12 2007-02-22 University Health Network Methods and devices for lymphatic targeting
US20070087029A1 (en) 2005-10-14 2007-04-19 Pakala Syamasundar V Localized delivery to the lymphatic system
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2029106A2 (en) 2006-06-07 2009-03-04 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8858912B2 (en) * 2008-10-31 2014-10-14 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
CN102985131B (zh) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 用于递送siRNA的医疗装置
AU2011311255B2 (en) * 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
CA2797204C (en) 2010-04-28 2018-06-12 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
RU2570280C2 (ru) * 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
PT2768942T (pt) * 2011-10-17 2020-01-21 Massachusetts Inst Technology Entrega intracelular
US20170246439A9 (en) * 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
BR112014009713A2 (pt) * 2011-10-27 2017-04-18 Kimberly Clark Co administração transdérmica de agentes bioativos de alta viscosidade
WO2013166162A1 (en) * 2012-05-01 2013-11-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Tip-loaded microneedle arrays for transdermal insertion
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
BR112015020328B1 (pt) 2013-02-28 2022-05-31 Sorrento Therapeutics, Inc Dispositivo de aplicação transdérmica de droga
CN105209104A (zh) 2013-05-23 2015-12-30 金伯利-克拉克环球有限公司 具有改进的开放通道横截面几何形状的微针
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych

Also Published As

Publication number Publication date
CA2991459A1 (en) 2017-02-02
CN107949418B (zh) 2024-07-02
ES2893673T3 (es) 2022-02-09
JP2023015135A (ja) 2023-01-31
EP3325081A2 (en) 2018-05-30
AU2016297832B2 (en) 2020-07-16
MX2022014634A (es) 2023-01-18
DK3325081T3 (da) 2021-10-11
BR112018001435A2 (pt) 2018-09-11
JP6929829B2 (ja) 2021-09-01
HUE056424T2 (hu) 2022-02-28
RU2719946C2 (ru) 2020-04-23
KR20180035210A (ko) 2018-04-05
RU2018104104A (ru) 2019-08-26
AU2020233748B2 (en) 2022-08-25
RU2018104104A3 (pl) 2019-10-31
AU2016297832A1 (en) 2018-02-15
AU2020233748A1 (en) 2020-10-08
US20200338329A1 (en) 2020-10-29
EP3325081A4 (en) 2019-04-10
AU2022275393A1 (en) 2023-01-05
EP3922238A1 (en) 2021-12-15
JP2021185160A (ja) 2021-12-09
US20240181235A1 (en) 2024-06-06
MX2018000126A (es) 2018-03-23
WO2017019535A2 (en) 2017-02-02
EP3325081B1 (en) 2021-09-08
JP7167272B2 (ja) 2022-11-08
CN107949418A (zh) 2018-04-20
US10737082B2 (en) 2020-08-11
JP2018522002A (ja) 2018-08-09
US20180193625A1 (en) 2018-07-12

Similar Documents

Publication Publication Date Title
PL3325081T3 (pl) Sposoby dostarczania limfatycznego środków czynnych
SG10201912416QA (en) Therapeutic agents
PL3386484T3 (pl) Kompozycje i sposoby dostarczania środków terapeutycznych
IL250685A0 (en) Medicinal substance induces cytotoxicity
GB201701039D0 (en) Vertically integrated continuous delivery of an application
ZA201506916B (en) Microstructure array for delivery of active agents
ZA201903467B (en) Transdermal delivery of large agents
GB201509893D0 (en) Therapeutic agents
AU2016297823B2 (en) Methods for better delivery of active agents to tumors
IL249455A0 (en) Complexes of mineral-amino acids with active substances
GB201517263D0 (en) Therapeutic agents
GB201410816D0 (en) Therapeutic agents
GB201509885D0 (en) Therapeutic agents
GB201410815D0 (en) Therapeutic agents
HUE060732T2 (hu) Terápiás szer fibrózisra
GB201410817D0 (en) Therapeutic agents
GB201509888D0 (en) Therapeutic agents
GB201511126D0 (en) Spray device for the delivery of therapeutic agents
GB201410507D0 (en) Drug delivery enhancement agents
GB201513299D0 (en) Therapeutic agents
EP3094347A4 (en) Methods for enhancing the delivery of active agents
ZA201800163B (en) New anti-malarial agents
GB201409653D0 (en) Pyrrolobenzodiazepine therapeutic agents
GB201521767D0 (en) Therapeutic agents
GB201517264D0 (en) Therapeutic agents